Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Long-Term Debt Repayments (2016 - 2018)

Lisata Therapeutics (LSTA) has disclosed Long-Term Debt Repayments for 9 consecutive years, with $23000.0 as the latest value for Q3 2018.

  • For the quarter ending Q3 2018, Long-Term Debt Repayments changed N/A year-over-year to $23000.0, compared with a TTM value of -$4.5 million through Sep 2018, down 180.11%, and an annual FY2018 reading of $159000.0, down 83.52% over the prior year.
  • Long-Term Debt Repayments was $23000.0 for Q3 2018 at Lisata Therapeutics, down from $69000.0 in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $6.3 million in Q1 2016 and bottomed at -$4.7 million in Q4 2017.
  • Average Long-Term Debt Repayments over 5 years is $963382.5, with a median of $280133.0 recorded in 2014.
  • The sharpest move saw Long-Term Debt Repayments skyrocketed 1696.53% in 2014, then plummeted 98.74% in 2018.
  • Year by year, Long-Term Debt Repayments stood at $359668.0 in 2014, then skyrocketed by 165.34% to $954326.0 in 2015, then surged by 214.36% to $3.0 million in 2016, then crashed by 256.21% to -$4.7 million in 2017, then soared by 100.49% to $23000.0 in 2018.
  • Business Quant data shows Long-Term Debt Repayments for LSTA at $23000.0 in Q3 2018, $69000.0 in Q2 2018, and $67000.0 in Q1 2018.